Adenosine A2A Receptor Blockade or Deletion Diminishes Fibrocyte Accumulation in the Skin in a Murine Model of Scleroderma, Bleomycin-induced Fibrosis
Peripheral blood fibrocytes are a newly identified circulating leukocyte subpopulation that migrates into injured tissue where it may display fibroblast-like properties and participate in wound healing and fibrosis of skin and other organs. Previous studies in our lab demonstrated that A2A receptor-deficient and A2A antagonist-treated mice were protected from developing bleomycin-induced dermal fibrosis, thus the aim of this study was to determine whether the adenosine A2A receptor regulates recruitment of fibrocytes to the dermis in this bleomycin-induced model of dermal fibrosis. Sections of skin from normal mice and bleomycin-treated wild type, A2A knockout and A2A antagonist-treated mice were stained for Procollagen α2 Type I and CD34 and the double stained cells, fibrocytes, were counted in the tissue sections. There were more fibrocytes in the dermis of bleomycin-treated mice than normal mice and the increase was abrogated by deletion or blockade of adenosine A2A receptors. Because fibrocytes play a central role in tissue fibrosis these results suggest that diminished adenosine A2A receptor-mediated recruitment of fibrocytes into tissue may play a role in the pathogenesis of fibrosing diseases of the skin. Moreover, these results provide further evidence that adenosine A2A receptors may represent a new target for the treatment of such fibrosing diseases as scleroderma or nephrogenic fibrosing dermopathy.
KEY WORDSfibrocyte adenosine A2A receptor scleroderma
adenosine A2A receptor knockout
This work was supported by grants from the National Institutes of Health (AR41911, AA13336, GM56268), the Scleroderma Foundation, King Pharmaceuticals, the General Clinical Research Center (M01RR00096) and by the Kaplan Cancer Center of New York University School of Medicine.
- 2.Chan, E. S., P. Fernandez, A. A. Merchant, M. C. Montesinos, S. Trzaska, A. Desai et al. 2006. Adenosine A2A receptors in diffuse dermal fibrosis: pathogenic role in human dermal fibroblasts and in a murine model of scleroderma. Arthritis Rheum. 54:2632–2642, doi: 10.1002/art.21974.PubMedCrossRefGoogle Scholar
- 7.Murakami, S., M. Terakura, T. Kamatani, T. Hashikawa, T. Saho, Y. Shimabukuro et al. 2000. Adenosine regulates the production of interleukin-6 by human gingival fibroblasts via cyclic AMP/protein kinase A pathway. J. Periodontal. Res. 35:93–101, doi: 10.1034/j.1600-0765.2000.035002093.x.PubMedCrossRefGoogle Scholar
- 9.Che, J., E. S. Chan, and B. N. Cronstein. 2007. Adenosine A2A receptor occupancy stimulates collagen expression by hepatic stellate cells via pathways involving protein kinase A, Src, and extracellular signal-regulated kinases 1/2 signaling cascade or p38 mitogen-activated protein kinase signaling pathway. Mol. Pharmacol. 72:1626–1636, doi: 10.1124/mol.107.03876.PubMedCrossRefGoogle Scholar
- 15.Chunn, J. L., A. Mohsenin, H. W. Young, C. G. Lee, J. A. Elias, R. E. Kellems et al. 2006. Partially adenosine deaminase-deficient mice develop pulmonary fibrosis in association with adenosine elevations. Am. J. Physiol. Lung Cell Mol. Physiol. 290:L579–L587, doi: 10.1152/ajplung.00258.2005.PubMedCrossRefGoogle Scholar
- 21.Ishida, Y., A. Kimura, T. Kondo, T. Hayashi, M. Ueno, N. Takakura, et al. 2007. Essential roles of the CC chemokine ligand 3-CC chemokine receptor 5 axis in bleomycin-induced pulmonary fibrosis through regulation of macrophage and fibrocyte infiltration. Am. J. Pathol. 170:843–854 doi: 10.2353/ajpath.2007.051213.PubMedCrossRefGoogle Scholar
- 24.Montesinos, M., J. F. Chen, A. Desai, H. Yee, M. Jacobson, M. Schwarzschild, et al. 2002. Adenosine promotes wound healing and mediates angiogenesis in response to tissue injury via occupancy of A2A receptors. Am. J. Pathol. 160:2000–2009.Google Scholar
- 26.Desai, A., C. Victor-Vega, S. Gadangi, M. C. Montesinos, C. C. Chu, and B. N. Cronstein. 2005. Adenosine A2A receptor stimulation increases angiogenesis by down-regulating production of the antiangiogenic matrix protein thrombospondin 1. Mol. Pharmacol. 67:1406–1413, doi: 10.1124/mol.104.007807.PubMedCrossRefGoogle Scholar
- 27.Khoa, N. D., C. M. Montesinos, A. J. Williams, M. Kelly, and B. N. Cronstein. 2003. Th1 cytokines regulate adenosine receptors and their downstream signalling elements in human microvascular endothelial cells. J. Immunol. 171:3991–3998.Google Scholar